57 employees
Nivagen Pharmaceuticals engages in the development, acquisition, and sales of generic prescription drugs and over the counter products.
2009
$16M
from 1 investors over 1 rounds
Nivagen Pharmaceuticals, Inc. raised $16M on May 19, 2020
Investors: Telegraph Hill Partners